GENEVA, May 3 -- HANGZHOU JIAYIN BIOTECH LTD. (Room 401 Building 11, Hexiang Science and Technology Center, Qiantang DistrictHangzhou, Zhejiang 310018), EXEGENESIS BIO CO. (727 Norristown Road, Suite 160, Building 3, Spring House Innovation Park, Lower Gwynedd Pennsylvania19002), EXEGENESIS BIO SINGAPORE PTE. LTD. (6 Raffles Quay, #14-06048580) filed a patent application (PCT/CN2025/129348) for "A NOVEL INTRAVITREAL GENE THERAPY FOR NEOVASCULAR DISEASES" on Oct 22, 2025. With publication no. WO/2026/086836, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property O...